Suggest an update

YC W20 · Active

Isabl

Cancer tests based on whole genome and transcriptome data.

Class
Winter 2020
Status
Active
Industry
Healthcare
Location
New York City, NY, USA; New York, NY, USA; Remote
Team size
5

Website

http://isabl.io

About

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.